Rapamycin inhibits vascular smooth muscle cell migration.
Abnormal vascular smooth muscle cell (SMC) proliferation and migration contribute to the development of restenosis after percutaneous transluminal coronary angioplasty and accelerated arteriopathy after cardiac transplantation. Previously, we reported that the macrolide antibiotic rapamycin, but not...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1996
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507677/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8941644/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119038 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
